Michael P Carducci1, Zachary R Zimmer2, Andrew Jawa3. 1. Department of Orthopaedic Surgery, New England Baptist Hospital, Boston, MA, USA; Department of Research, Boston Sports and Shoulder Center, Waltham, MA, USA. 2. Department of Orthopaedic Surgery, Massachusetts General Hospital, Boston, MA, USA. 3. Department of Orthopaedic Surgery, New England Baptist Hospital, Boston, MA, USA; Department of Research, Boston Sports and Shoulder Center, Waltham, MA, USA. Electronic address: andrewjawa@gmail.com.
Abstract
BACKGROUND: Despite favorable clinical and functional results for reverse total shoulder arthroplasty (RSA), there remains a group of patients without postoperative complications who demonstrate poor improvement and overall outcome. METHODS: Using a single surgeon shoulder arthroplasty registry, we identified patients who underwent RSA from 2013 to 2016 with minimum of 2-year postoperative follow-up. Patients with intra- and postoperative complications were excluded. Poor postoperative clinical outcome was defined as those patients within the bottom 30th percentile for American Shoulder and Elbow Surgeons (ASES) score. Poor postoperative improvement was defined as the bottom 30th percentile of ASES improvement, measured preoperatively to the 2-year postoperative mark. Multivariate logistic regression modeling was used to determine preoperative characteristics (e.g., demographics, comorbidities, preoperative ASES score) associated with poor outcome. RESULTS: A total of 137 patients met the inclusion and exclusion criteria. Multivariable logistic regression modeling found that prior shoulder surgery, the majority (75%) of which were arthroscopic, was the only independent factor associated with both poor improvement (adjusted odds ratio, 2.46 [1.03-5.83]) and outcome (adjusted odds ratio, 4.92 [1.74-14.96]). Preoperative opioid use was associated with poor outcomes only, whereas the high preoperative ASES score was associated with poor postoperative improvement. CONCLUSIONS: Prior ipsilateral shoulder surgery was strongly associated with poor clinical improvement and outcome after RSA. No other factors correlated with both poor improvement and outcome. This association is important to decision making for any shoulder surgery, given the long-term implications.
BACKGROUND: Despite favorable clinical and functional results for reverse total shoulder arthroplasty (RSA), there remains a group of patients without postoperative complications who demonstrate poor improvement and overall outcome. METHODS: Using a single surgeon shoulder arthroplasty registry, we identified patients who underwent RSA from 2013 to 2016 with minimum of 2-year postoperative follow-up. Patients with intra- and postoperative complications were excluded. Poor postoperative clinical outcome was defined as those patients within the bottom 30th percentile for American Shoulder and Elbow Surgeons (ASES) score. Poor postoperative improvement was defined as the bottom 30th percentile of ASES improvement, measured preoperatively to the 2-year postoperative mark. Multivariate logistic regression modeling was used to determine preoperative characteristics (e.g., demographics, comorbidities, preoperative ASES score) associated with poor outcome. RESULTS: A total of 137 patients met the inclusion and exclusion criteria. Multivariable logistic regression modeling found that prior shoulder surgery, the majority (75%) of which were arthroscopic, was the only independent factor associated with both poor improvement (adjusted odds ratio, 2.46 [1.03-5.83]) and outcome (adjusted odds ratio, 4.92 [1.74-14.96]). Preoperative opioid use was associated with poor outcomes only, whereas the high preoperative ASES score was associated with poor postoperative improvement. CONCLUSIONS: Prior ipsilateral shoulder surgery was strongly associated with poor clinical improvement and outcome after RSA. No other factors correlated with both poor improvement and outcome. This association is important to decision making for any shoulder surgery, given the long-term implications.
Authors: Fabian Plachel; Paul Siegert; Philipp Moroder; Leo Pauzenberger; Brenda Laky; Werner Anderl; Philipp Heuberer Journal: BMC Musculoskelet Disord Date: 2021-02-16 Impact factor: 2.362
Authors: Corey C Spencer; Jeremiah A Pflederer; Jacob M Wilson; Alexander M Dawes; Michael B Gottschalk; Eric R Wagner Journal: JSES Int Date: 2021-04-03
Authors: Sai K Devana; Akash A Shah; Changhee Lee; Varun Gudapati; Andrew R Jensen; Edward Cheung; Carlos Solorzano; Mihaela van der Schaar; Nelson F SooHoo Journal: J Shoulder Elb Arthroplast Date: 2021-10-28